Recent scores in acs or heart failure
Reading File
Finding Sources
Finding Sources
Searching PubMed
risk score ACS heart failure prediction
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Now I have comprehensive information. Let me compile a thorough answer.
Clinical Risk Scores in ACS & Heart Failure
ACS Risk Scores
1. TIMI Score (NSTE-ACS)
The TIMI (Thrombolysis in Myocardial Infarction) risk score predicts 14-day risk of death, new/recurrent MI, or urgent revascularization.
| Variable | Points |
|---|---|
| Age ≥ 65 years | 1 |
| ≥ 3 CAD risk factors (FHx, DM, HTN, hyperlipidemia, tobacco) | 1 |
| Known CAD (≥ 50% stenosis) | 1 |
| ST deviation > 0.5 mm on presenting ECG | 1 |
| ≥ 2 anginal events in prior 24 h | 1 |
| Prior aspirin use | 1 |
| Elevated cardiac markers | 1 |
Score interpretation — 14-day adverse event rate:
| Score | Risk (%) |
|---|---|
| 0–1 | 5% |
| 2 | 8% |
| 3 | 13% |
| 4 | 20% |
| 5 | 26% |
| 6–7 | 41% |
Use: TIMI ≤ 1 → ischemia-driven (conservative) strategy; TIMI ≥ 3 → early invasive strategy (within 24 h).
- Harrison's Principles of Internal Medicine 22E, p. 2151; Washington Manual, p. 135
2. GRACE Score (NSTE-ACS / STEMI)
The GRACE (Global Registry of Acute Coronary Events) score was derived from >100,000 real-world ACS patients and predicts in-hospital and 6-month mortality.
Variables (continuous, nomogram-based):
- Age
- Heart rate
- Systolic blood pressure
- Creatinine
- Killip class at presentation
- Cardiac arrest at admission
- ST deviation
- Elevated cardiac enzymes
GRACE thresholds for invasive strategy (NSTEMI/UA):
| Strategy | GRACE |
|---|---|
| Ischemia-driven (low risk) | < 109 |
| Early invasive within 24 h (high risk) | > 140 |
| Immediate/urgent ≤ 2 h | Regardless (if hemodynamically unstable, sustained VT/VF) |
- Washington Manual, p. 136
3. HEART Score (Emergency Department)
The HEART score was specifically developed for ED chest pain evaluation — unlike TIMI/GRACE, it is designed to identify patients safe for discharge.
| Variable | 0 | 1 | 2 |
|---|---|---|---|
| History | Nonspecific | Mixed | Typical for ACS |
| ECG | Normal | Non-specific repolarization change | Significant ST deviation |
| Age | < 45 | 45–64 | ≥ 65 |
| Risk Factors | None | 1–2 | ≥ 3 OR documented atherosclerosis |
| Troponin | ≤ normal | 1–3× normal | > 3× normal |
Score interpretation:
| Score | Risk Category | Action |
|---|---|---|
| 0–3 | Low | Candidate for early discharge |
| 4–6 | Moderate | Observation + further evaluation |
| 7–10 | High | Urgent/emergent intervention |
The HEART Pathway uses HEART score + serial troponin (0 h and 3 h). HEART score 0–3 with no troponin elevation → < 1% MACE risk at 30–60 days → safe discharge.
- Rosen's Emergency Medicine, p. 1020; Tintinalli's Emergency Medicine, p. 400
4. HEAR Score (HEART Pathway subset)
HEAR = HEART score without the Troponin component (H, E, A, R items only, max 8 points).
- Score 0–3 (no known CAD, no ischemic ECG changes): calculate further to confirm low-risk before discharge.
- Score ≥ 4: high-risk → admit for testing.
5. EDACS (Emergency Department Assessment of Chest Pain Score)
A newer alternative designed specifically for ED use with serial troponins.
- EDACS < 16 with negative troponins at 0 h and 2 h → < 1% MACE risk → safe discharge.
Heart Failure Risk Scores
Heart failure has multiple validated scores depending on the clinical context:
| Score | Setting | Predicts |
|---|---|---|
| MAGGIC | Chronic HF | 1- and 3-year mortality (12 variables incl. EF, age, BMI, NYHA) |
| CHARM | Outpatient HF (HFrEF) | CV death/HF hospitalization |
| GWTG-HF | In-hospital / acute HF | In-hospital mortality (age, SBP, BUN, Na, HR, COPD, non-Black race) |
| ADHERE | Acute decompensated HF | In-hospital mortality using BUN, creatinine, SBP |
| Seattle Heart Failure Model | Ambulatory HF | 1-, 2-, 5-year survival; guides device/transplant decisions |
| BIOSTAT-CHF | HF with biomarkers | Mortality + re-hospitalization using NT-proBNP, BNP |
| NYHA Class | All HF | Functional classification (I–IV); used in all trials and guidelines |
GWTG-HF key predictors: BUN > 43 mg/dL, SBP < 115 mmHg, creatinine > 2.75 mg/dL → highest in-hospital mortality risk.
Seattle Heart Failure Model is the most comprehensive ambulatory tool and is used clinically to guide decisions about ICD, CRT, LVAD, and transplant listing.
Summary Table
| Score | Disease | Setting | Primary Endpoint |
|---|---|---|---|
| TIMI | NSTE-ACS | Inpatient | 14-day death/MI/revasc |
| GRACE | ACS (all) | Inpatient | In-hospital + 6-month mortality |
| HEART | ACS | ED | MACE at 30–60 days |
| HEAR | ACS | ED | Low-risk discharge triage |
| EDACS | ACS | ED | MACE at 30–60 days |
| GWTG-HF | Acute HF | In-hospital | In-hospital mortality |
| MAGGIC | Chronic HF | Outpatient | 1–3 year mortality |
| Seattle HF | Chronic HF | Outpatient | 1–5 year survival |
Key clinical point: TIMI and GRACE were derived from inpatients to guide revascularization decisions — they are not designed for ED discharge decisions. HEART, HEAR, and EDACS were specifically designed for that purpose and have largely replaced TIMI in the ED. — Rosen's Emergency Medicine, p. 1020
Give some suggestions for emergency medicine thesis regarding some score studies valid in emergency
Searching PubMed
HEART score validation emergency department
Searching PubMed
risk score sepsis emergency department validation
Searching PubMed
clinical score prediction emergency department outcome
Searching the Web
emergency medicine thesis topics risk score validation 2024 2025
I have excellent material. Let me now compile well-organized thesis suggestions.
Emergency Medicine Thesis Ideas: Risk Score Studies
Here are 15 practical, publishable thesis topics organized by clinical domain, each framed as a feasible prospective or retrospective validation study suitable for an MD/residency thesis.
I. Chest Pain / ACS
1. Comparative Validation of HEART vs. TIMI in Your Local ED
Design: Prospective observational cohort
Question: Does the HEART score outperform TIMI in identifying 30-day MACE in patients presenting with undifferentiated chest pain to your ED?
Why relevant: TIMI was derived from inpatients; a 2026 federated meta-analysis (PMID: 41943236) confirms HEART score performance across diverse EDs, but local validation in resource-limited or non-Western settings is still needed.
Primary endpoint: MACE (death, MI, urgent revascularization) at 30 days
Feasibility: 200–300 patients over 6 months is adequate
Question: Does the HEART score outperform TIMI in identifying 30-day MACE in patients presenting with undifferentiated chest pain to your ED?
Why relevant: TIMI was derived from inpatients; a 2026 federated meta-analysis (PMID: 41943236) confirms HEART score performance across diverse EDs, but local validation in resource-limited or non-Western settings is still needed.
Primary endpoint: MACE (death, MI, urgent revascularization) at 30 days
Feasibility: 200–300 patients over 6 months is adequate
2. HEART Pathway with High-Sensitivity Troponin at 0 h and 1 h
Design: Prospective, single-center
Question: Can the HEART Pathway using 0h/1h hsTnI safely rule out ACS with < 1% miss rate in your ED?
Why relevant: Most validation studies are from high-income countries; 0h/1h algorithms are now guideline-recommended but not yet universally adopted
Comparison: 0h/1h vs. 0h/3h standard troponin protocol
Question: Can the HEART Pathway using 0h/1h hsTnI safely rule out ACS with < 1% miss rate in your ED?
Why relevant: Most validation studies are from high-income countries; 0h/1h algorithms are now guideline-recommended but not yet universally adopted
Comparison: 0h/1h vs. 0h/3h standard troponin protocol
3. EDACS vs. HEART Score: Which Is Better for Early Discharge?
Design: Prospective head-to-head comparison
Question: Do EDACS (< 16) and HEART (0–3) identify equivalent proportions of low-risk patients for discharge, and is the miss rate comparable?
Endpoint: 30-day MACE; proportion safely discharged
Question: Do EDACS (< 16) and HEART (0–3) identify equivalent proportions of low-risk patients for discharge, and is the miss rate comparable?
Endpoint: 30-day MACE; proportion safely discharged
II. Sepsis & Infection
4. qSOFA vs. NEWS2 for In-Hospital Deterioration Prediction in ED Sepsis
Design: Retrospective or prospective cohort
Question: Which score better predicts ICU transfer or 28-day mortality among ED sepsis patients — qSOFA (≥ 2) or NEWS2 (≥ 5)?
Why timely: A 2025 systematic review (PMID: 40313231) highlights prehospital early warning scores for short-term mortality prediction; your study extends this to the ED
Endpoints: ICU admission, 28-day mortality, length of stay
Question: Which score better predicts ICU transfer or 28-day mortality among ED sepsis patients — qSOFA (≥ 2) or NEWS2 (≥ 5)?
Why timely: A 2025 systematic review (PMID: 40313231) highlights prehospital early warning scores for short-term mortality prediction; your study extends this to the ED
Endpoints: ICU admission, 28-day mortality, length of stay
5. Validation of the SOFA Score at ED Triage for Sepsis Mortality
Design: Prospective
Question: What is the discriminative value (AUROC) of the SOFA score calculated at ED triage (within 1 hour) for 28-day mortality?
Value added: Most SOFA data come from ICUs; early ED SOFA data are sparse
Question: What is the discriminative value (AUROC) of the SOFA score calculated at ED triage (within 1 hour) for 28-day mortality?
Value added: Most SOFA data come from ICUs; early ED SOFA data are sparse
6. Bacteremia Prediction Models in the ED — External Validation
Design: Retrospective chart review
Question: Validate the McIsaac, Shapiro, or Bates bacteremia prediction models in your ED patient population
Why relevant: A 2024 systematic review (PMID: 38318742) found major gaps in external validation of bacteremia prediction models across different health systems
Question: Validate the McIsaac, Shapiro, or Bates bacteremia prediction models in your ED patient population
Why relevant: A 2024 systematic review (PMID: 38318742) found major gaps in external validation of bacteremia prediction models across different health systems
III. Pulmonary Embolism
7. Wells Score vs. PERC Rule: Safety and Utility in Low-Resource ED
Design: Prospective observational
Question: In patients presenting with suspected PE, can PERC (score = 0) safely exclude PE without further workup, and what proportion of CT-PA scans could be avoided?
Endpoints: CT-PA utilization rate, PE diagnosis rate, 3-month VTE events
Practical value: High CT-PA overuse in EDs — this study directly impacts resource stewardship
Question: In patients presenting with suspected PE, can PERC (score = 0) safely exclude PE without further workup, and what proportion of CT-PA scans could be avoided?
Endpoints: CT-PA utilization rate, PE diagnosis rate, 3-month VTE events
Practical value: High CT-PA overuse in EDs — this study directly impacts resource stewardship
8. Simplified PESI vs. sPESI for Home Discharge Decisions in Low-Risk PE
Design: Prospective cohort
Question: Can sPESI = 0 reliably identify PE patients safe for outpatient treatment in your population?
Why relevant: A 2024 meta-analysis (PMID: 38993086) confirms safety of home PE treatment; local validation is needed before institutional adoption
Endpoint: 30-day adverse events (recurrent VTE, major bleeding, death)
Question: Can sPESI = 0 reliably identify PE patients safe for outpatient treatment in your population?
Why relevant: A 2024 meta-analysis (PMID: 38993086) confirms safety of home PE treatment; local validation is needed before institutional adoption
Endpoint: 30-day adverse events (recurrent VTE, major bleeding, death)
IV. Trauma
9. Validation of the Shock Index in Predicting Massive Transfusion in Trauma
Design: Retrospective (trauma registry) or prospective
Question: Does Shock Index (HR/SBP) ≥ 1.0 at ED arrival predict need for massive transfusion protocol activation?
Secondary outcomes: 24-h mortality, ICU admission
Feasibility: Excellent — all variables available in any triage record
Question: Does Shock Index (HR/SBP) ≥ 1.0 at ED arrival predict need for massive transfusion protocol activation?
Secondary outcomes: 24-h mortality, ICU admission
Feasibility: Excellent — all variables available in any triage record
10. Glasgow Coma Scale vs. FOUR Score in ED Head Trauma
Design: Prospective
Question: In patients with altered consciousness after head trauma, does the FOUR (Full Outline of UnResponsiveness) score predict ICU admission and 7-day neurological outcome better than GCS?
Why novel: GCS cannot assess brainstem reflexes or breathing pattern — FOUR captures these but is underused
Question: In patients with altered consciousness after head trauma, does the FOUR (Full Outline of UnResponsiveness) score predict ICU admission and 7-day neurological outcome better than GCS?
Why novel: GCS cannot assess brainstem reflexes or breathing pattern — FOUR captures these but is underused
V. Dyspnea / Heart Failure
11. BNP/NT-proBNP Cutoffs + Clinical Scores for Acute Dyspnea Differentiation in the ED
Design: Prospective
Question: What combination of BNP + BREATHE score (or Framingham criteria) best discriminates acute HF from non-cardiac dyspnea in ED patients?
Why relevant: A 2025 meta-analysis (PMID: 40219913) shows machine learning improves natriuretic peptide use — your study benchmarks simpler clinical tools in real-world ED settings
Question: What combination of BNP + BREATHE score (or Framingham criteria) best discriminates acute HF from non-cardiac dyspnea in ED patients?
Why relevant: A 2025 meta-analysis (PMID: 40219913) shows machine learning improves natriuretic peptide use — your study benchmarks simpler clinical tools in real-world ED settings
12. GWTG-HF Score Validation for Acute Decompensated Heart Failure Outcomes
Design: Retrospective cohort
Question: Does the GWTG-HF score calculated at ED presentation predict in-hospital mortality and ICU admission in acute decompensated HF patients at your institution?
Question: Does the GWTG-HF score calculated at ED presentation predict in-hospital mortality and ICU admission in acute decompensated HF patients at your institution?
VI. Stroke / Neurology
13. ROSIER Score Validation for Stroke Identification in the ED
Design: Prospective
Question: What is the sensitivity and specificity of ROSIER (Recognition of Stroke in Emergency Room) compared to final neuroimaging diagnosis in your local ED?
Clinical impact: Reduces time to CT and thrombolysis — directly impacts outcomes
Question: What is the sensitivity and specificity of ROSIER (Recognition of Stroke in Emergency Room) compared to final neuroimaging diagnosis in your local ED?
Clinical impact: Reduces time to CT and thrombolysis — directly impacts outcomes
14. NIHSS vs. ASPECTS Score: Correlation and Thrombolysis Decision-Making
Design: Retrospective
Question: Does combining NIHSS and ASPECTS score at ED presentation improve selection of appropriate thrombolysis candidates?
Question: Does combining NIHSS and ASPECTS score at ED presentation improve selection of appropriate thrombolysis candidates?
VII. Novel / High-Impact
15. Comparison of Machine Learning Algorithm vs. Traditional Risk Score (HEART/GRACE) for Adverse Cardiac Events
Design: Retrospective, using ED database
Question: Can a simple machine learning model trained on ED vitals + basic labs outperform HEART or GRACE in predicting 30-day MACE?
Why compelling: This is a growing area — publishable in Emergency Medicine journals and relevant to AI in healthcare
Tools required: Python/R; logistic regression + random forest vs. HEART
Question: Can a simple machine learning model trained on ED vitals + basic labs outperform HEART or GRACE in predicting 30-day MACE?
Why compelling: This is a growing area — publishable in Emergency Medicine journals and relevant to AI in healthcare
Tools required: Python/R; logistic regression + random forest vs. HEART
Choosing Your Thesis — Decision Framework
| Factor | Best Fit |
|---|---|
| Short timeline (< 6 months) | HEART pathway, Wells/PERC, qSOFA |
| Retrospective data available | GWTG-HF, Shock Index, HEART vs. TIMI |
| Prospective + strong clinical impact | HEART Pathway + hsTn, ROSIER, PERC |
| Quantitative/statistical strength | ML vs. HEART score comparison |
| Limited resources/rural ED | qSOFA validation, HEAR score |
Tips for scope:
- A validation study of an existing score in your local population (external validation) is the most feasible thesis design — you need 150–400 patients, one primary endpoint, and AUROC analysis.
- Pair any score study with decision impact analysis (would this score have changed clinical decisions?) to add novelty.
- Scores with gaps in non-Western validation (HEART, EDACS, sPESI, qSOFA) are the most publishable.
Some more different topics other than scoring sustems
Searching PubMed
emergency department biomarker diagnosis outcome
Searching PubMed
point of care ultrasound emergency diagnosis
Searching PubMed
emergency department triage outcomes crowding
Searching PubMed
procedural sedation analgesia emergency department
You've run out of free credits. Sign up for a free account to continue using Orris.
This is a shared conversation. Sign in to Orris to start your own chat.